Dáil debates

Thursday, 29 February 2024

Ceisteanna Eile (Atógáil) - Other Questions (Resumed)

Medicinal Products

9:50 am

Photo of Aindrias MoynihanAindrias Moynihan (Cork North West, Fianna Fail) | Oireachtas source

I first wish to acknowledge that significant work has been done on women's health across a range of different services. That is very positive. I refer to IVF, gynaecological services, for example, in Cork, and menopause clinics. This measure would complement the great effort that has been advanced through menopause clinics. A small number of people are involved in this and they have very limited options, if any at all. This is their first opportunity to have an option available to them because it is non-hormone-based drug. Their options are limited because of their cancer treatment, which means they will not be able to use any hormone-based drugs. Can the fact that very limited alternatives are available to these people inform the decision? Can it inform and expedite the decision to put it on the drugs payment scheme at a manageable price?

Comments

No comments

Log in or join to post a public comment.